Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 19Gynecologic 6Thoracic 5Head & Neck 5Breast 3Other solid neoplasm 1Dermatologic 1

Conditions

Triple Negative Breast Neoplasms 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1

Interventions

Trastuzumab 728Paclitaxel 694Cyclophosphamide 647Docetaxel 559Capecitabine 485Letrozole 437Fulvestrant 398Carboplatin 397Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 272exemestane 258Epirubicin 251Radiotherapy 239pertuzumab 237palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 151Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
TP protocol × Breast × Clear all
NCT03201861 2025-05-16

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

RenJi Hospital

Phase 3 Recruiting
762 enrolled
Breast

Carcinoma, Ductal, Breast

NCT04499118 2020-08-05

AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer

Sichuan Provincial People's Hospital

Phase 2 Unknown
100 enrolled
Breast

Breast Neoplasms

NCT01216111 2020-05-19

Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)

Fudan University

Phase 3 Completed
647 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡